Inventors:
David Claxton - Hummelstown PA, US
Robert Newman - Houston TX, US
International Classification:
A61K031/12, A61K007/00
Abstract:
The present invention concerns the use of methods and compositions to provide an improved lipid:emodin formulation for the treatment of leukemias expressing bcr-abl and other cancer with elevated tyrosine kinase activity.